LillyDirect (Zepbound) vs. Mochi Health: prices, fine print, and the honest verdict

Tirzepatide pricing

On tirzepatide, Mochi Health is the cheaper program at $278 a month all-in versus LillyDirect (Zepbound)'s $449 — a gap of $171 a month, $2,052 a year, at the 10 mg maintenance basis. LillyDirect (Zepbound): $449 a month all-in at the 10 mg maintenance basis, dose-scaled from a $299 entry, no membership fee. Mochi Health: $278 a month all-in at the 10 mg maintenance basis, flat at every dose from 2.5 to 15 mg, including the mandatory $79/mo membership.

Semaglutide pricing

Only Mochi Health publishes a semaglutide price here: Semaglutide runs $178 a month all-in. LillyDirect (Zepbound) doesn't sell compounded semaglutide — its lane is brand fulfillment.

Different products, not just different prices

LillyDirect (Zepbound) fulfills the FDA-approved product — reviewed manufacturing, verified identity and sterility, stable legal status — while Mochi Health sells compounded medication: pharmacy-prepared, not FDA-reviewed, and operating under the narrower post-shortage pathways our legal guide tracks. The compounded discount is partly a risk premium; whether it's worth taking depends on the pharmacy behind it and your tolerance for regulatory turbulence.

Transparency

LillyDirect (Zepbound): Source-verified (verified 2026-08-09); names its pharmacy — Eli Lilly direct / retail partners. Mochi Health: Source-verified (verified 2026-08-05); names its pharmacy — company-owned compounding facility. In this market, a named pharmacy and a dated, source-verified price are worth real money — they are what let you check the claim instead of trusting it.

Commitment & cancellation

LillyDirect (Zepbound): 45-day refill cadence to keep pricing; no subscription; refill-window rules apply. Mochi Health: membership recurs monthly; cancel membership any time; recurs until cancelled; $79/mo membership recurs until cancelled.

The gap, compounded over time

A $171/month difference sounds decidable by coin flip until it's annualized: choosing LillyDirect (Zepbound) over Mochi Health at the standing rates costs an extra one month, $171; six months, $1,026; a year, $2,052; two years of maintenance, $4,104. Every figure is the all-in maintenance basis; the arithmetic reruns from the dataset.

The 24-month ledger

Zoom to the horizon that matters for a chronic-use drug — 24 months — and LillyDirect (Zepbound) bills $10,776 and Mochi Health $6,672, a spread of $4,104 for the same molecule at the same 10 mg basis. Reference rails for the same 24 months: $5,160 at the verified floor, $10,776 on brand Zepbound at maintenance, $8,376 on Wegovy flat.

Two ladders, side by side

The 2.5-to-10 mg climb is the honest stress test: LillyDirect (Zepbound) steps $299 → $399 → $449 and holds $449 from 7.5 mg up (four-month titration: $1,596); Mochi Health holds $278 on every rung (four-month titration: exactly $1,112). A flat ladder makes dose decisions purely clinical; a scaled one attaches an invoice to every escalation — including the post-plateau bump from 10 to 12.5 mg that many patients eventually face. Full framework: the titration cost guide.

Three buyers, two invoices

The month-one starter pays $299 at LillyDirect (Zepbound) versus $278 at Mochi Health for the 2.5 mg rung — an early edge that holds once the ladder climbs. The settled 10 mg maintainer — the buyer our basis is built for — pays $3,336/year at Mochi Health against $5,388 at the other: $2,052 of annual daylight for the same molecule and dose.

The semaglutide board

Only Mochi Health fields a verified semaglutide price here — $178/month all-in (#6 of 19) — while LillyDirect (Zepbound) focuses its published pricing on tirzepatide. For a buyer starting on the cheaper molecule with a likely upgrade later, single-molecule programs mean a future re-shop; dual-molecule ones price the whole arc.

The five normalizations, applied to this pair

1 · All-in, not advertised. LillyDirect (Zepbound)'s ranked figure is $449, with no membership to add; Mochi Health's ranked figure is $278 ($199 medication + $79 mandatory membership). 2 · Maintenance basis. LillyDirect (Zepbound) scales from $299 to $449, and the 10 mg figure is the one ranked; Mochi Health is dose-flat, so its entry and 10 mg figures coincide. 3 · Terms separated. LillyDirect (Zepbound): standing $449, no prepaid tier; Mochi Health: standing $278, no prepaid tier — standing rates rank, prepaid effectives are labeled beside them. 4 · Evidence tiered. LillyDirect (Zepbound): source-verified, read 2026-08-09; Mochi Health: source-verified, read 2026-08-05. 5 · Pharmacy weighed. LillyDirect (Zepbound) names Eli Lilly direct / retail partners; Mochi Health names company-owned compounding facility — in a pharmacy-variance market, disclosure is a scored asset. Run the same five on any roundup you read and most published “cheapest” lists reorder themselves.

Fine print, itemized

LillyDirect (Zepbound): no membership — the medication figure is the billed figure; no subscription; refill-window rules apply; commitment: 45-day refill cadence to keep pricing. Mochi Health: a mandatory $79/mo membership folded into our all-in figure; cancel membership any time; recurs until cancelled; commitment: membership recurs monthly. The pattern to police on both sides is the same: memberships that outlive the medication order, renewal-relative cancellation deadlines, and prepaid terms whose refund language matters more than their discount in a year of live litigation. Cancel in writing; screenshot everything.

Transparency, audited

LillyDirect (Zepbound) carries source-verified pricing (last read 2026-08-09); pharmacy disclosure is its strong suit — Eli Lilly direct / retail partners, manufacturer direct. Mochi Health carries source-verified pricing (last read 2026-08-05); pharmacy disclosure is its strong suit — company-owned compounding facility, owned facility. Our weighting is unapologetic: in a market of identical molecule names, a dated source-verified price and a named pharmacy are the two claims a buyer can actually check, and they carry 25 of 100 formula points between them — the methodology shows the math, and the pharmacy guide decodes every answer the five questions can return.

Switching between them

Neither program locks the door: a LillyDirect (Zepbound)-to-Mochi Health move is a new intake, a new prescription at the new pharmacy, and a written cancellation at the old shop — typically a one-to-two-week overlap if you time the last fill. What does not move with you: prepaid months, membership balances, and any dose paperwork, so re-state your current rung clearly at the new intake.

Refills, shipping, and the week-to-week reality

Past the pricing page, the operational facts are what a subscriber lives with: LillyDirect (Zepbound): shipping included (or same-day retail pickup); consultation bring your own prescription (telehealth partners available); prescription required visit model; a ~45-day refill cadence guards the self-pay tiers (lapse and fills reprice $599–$1,049 until re-enrollment). Mochi Health: shipping included; consultation video visits included in membership; video visit model. Cold-chain shipments run 3–7 days across the market; the recurring failure modes are refill-timing gaps and pharmacy backlogs, so whichever program wins here, order refills a week early and confirm the pharmacy’s current turnaround at intake.

Who should pick which

Pick LillyDirect (Zepbound) if only the FDA-approved product will do; you refuse membership fees on principle. Pick Mochi Health if the $171/month tirzepatide saving is the point; you want a price that survives titration; unlimited included clinician and dietitian visits matter more than the last $60. Neither answer is universal — which is the argument for choosing from data with dates on it rather than from whichever ad loaded first.

If neither one fits

Two programs never exhaust the market — the nearest substitutes on the verified board are Fridays at $359 (flat, no membership); Lavender Sky Health at $352 (dose-scaled, $25 membership included); Henry Meds at $349 (flat, no membership) — or skip straight to the rankings page, where every standard “cheapest / best / no-commitment” question is answered in one sourced sentence.

The verdict

On the numbers alone, Mochi Health is the cheaper tirzepatide program by $171/mo and it doesn't trade that price for opacity ; LillyDirect (Zepbound)'s case rests on FDA-approved product. Both records, with dates and sources, live in the pricing database.